Biocompatible 3D Printing Materials Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.51 Billion |
| Market Size (2030) | USD 3.92 Billion |
| CAGR (2025 - 2030) | 20.99% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Biocompatible 3D Printing Materials Market Analysis
The Biocompatible 3D Printing Materials Market size is estimated at USD 1.51 billion in 2025, and is expected to reach USD 3.92 billion by 2030, at a CAGR of 20.99% during the forecast period (2025-2030).
Factors such as the high adoption of 3D printing technology in the healthcare industry and the mass customization of biocompatible 3D printing materials are expected to drive market growth during the forecast period.
Continuous advancements in 3D printing technology, such as improved printing resolution, speed, and the availability of a wider range of materials, have made biocompatible 3D printing more feasible and accessible. This has encouraged researchers, engineers, and medical professionals to explore and utilize the technology for various applications. For instance, according to the article published in January 2023 in the Digital Health journal, there is a rapid opportunity for 3D printing in hospitals owing to its specific medical applications, medical subspecialty overviews, general 3D printing technology, and advancements in clinical practice. Hence, owing to the various advantages offered by 3D printing technologies in the medical field, their adoption is likely to increase, leading to market growth over the forecast period.
Also, several companies and research institutes are working towards advancements in biocompatible 3D printing solutions. For instance, in March 2023, experts from the University of Birmingham developed new techniques for 3D bioprinting that will enhance health outcomes, lower cost, and accelerate the production of tissue-compatible artificially created organs. Additionally, in March 2022, Brinter, a Finland-based bioprinting company, partnered with Tampere University’s Kellomäki Lab Biomaterials and Tissue Engineering Group to develop new bio-inks for 3D printing and advance progress within the bioprinting field. With such developments in biocompatible 3D printing, the market studied is expected to witness significant growth in the coming years.
Thus, owing to the increase in the adoption of 3D printing in the medical field, the rise in product launches, and significant strategic activities by the global market players, the market is expected to witness notable growth during the forecast period. However, the high cost associated with 3D printing materials hinders market growth in the long run.
Biocompatible 3D Printing Materials Market Trends
The Implants and Prosthesis Segment is Expected to Witness Significant Growth During the Forecast Period
Biocompatible 3D printing materials offer the advantage of customization. They allow implants and prostheses to be tailored to the individual patient's needs, resulting in better fit, improved functionality, and enhanced patient satisfaction. The flexibility and versatility of biocompatible 3D printing technology have revolutionized the field of implantology and prosthetics, providing innovative solutions for various medical conditions and patient-specific requirements. Technological advancements in 3D printing technology and increasing demand for implants are key factors propelling segment growth.
Several companies and startups are developing new technologies. For instance, in November 2022, the Indian Institute of Science (IISc) and deep-tech hardware firm Prayasta developed a 3D printer for implant-grade silicon. The two organizations worked collaboratively to accelerate the transition of customized soft tissue implants from research to commercialization. The business is conducting animal experiments on 3D silicon implants before beginning the clinical trial. In addition to implants, they have created external prostheses and plan to commercialize them.
Furthermore, in March 2023, Invibio Biomaterial Solutions launched its PEEK-OPTIMA AM Filament, an implantable PEEK polymer for additive manufacturing. The device benefits medical device manufacturers as they assess the FFF/FDM route of additive manufacturing to help support medical device developments, such as CMF devices and spinal and orthopedic implants. Such advancements from the new companies will likely contribute to the segment's growth in the coming years. Similarly, in April 2023, Curiteva launched a 3D-printed spinal implant developed via the Inspire platform. The Inspire platform was designed with a patented fused fluid fabrication 3D printer.
Hence, with the launch of such implants and prosthesis products using 3D printing technology and biocompatible material, the segment is expected to grow considerably during the forecast period.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is expected to hold a significant share of the biocompatible 3D printing materials market, which is majorly due to the high adoption of technology, increasing focus on the development of the healthcare industry, and the presence of biomaterial manufacturers in the region.
The increasing number of new product launches in the 3D printing space drives the demand for 3D printing materials. For instance, in April 2023, 3D printer original equipment manufacturer (OEM) Stratasys and Ricoh partnered to provide on-demand 3D printed anatomic models for clinical settings. Medical personnel can quickly plan and perform complex operations with the help of Stratasys' patient-specific 3D solutions, improving communication between the care team, the patient, and their family. With such new developments in 3D printing, the demand for 3D printing materials will likely boost in the coming years.
Also, 3D printing is gaining significant attention in the United States, contributing to market growth. For instance, in October 2023, SprintRay Inc., a company focused on digital dentistry and dental 3D printing solutions, launched its OnX Tough 2, one of the 3D printing resins with fixed, implant-supported denture prosthetics. The United States and Canada are home to several prominent biocompatible 3D printing material companies. These companies are involved in the manufacturing, distributing, and developing of biocompatible materials and associated technologies. Examples of such companies include Stratasys, 3D Systems, Formlabs, Carbon, and EnvisionTEC.
Therefore, with the increasing number of new product launches and the presence of biocompatible 3D printing material manufacturers, North America is expected to hold a significant share of the market.
Biocompatible 3D Printing Materials Industry Overview
The biocompatible 3D printing materials market is semi-consolidated, with a few major players. Several new companies are entering the market with technological innovations. Some key companies operating in the market include 3D Systems Inc., Stratasys, GE Healthcare, Formlabs, and Evonik Industries.
Biocompatible 3D Printing Materials Market Leaders
-
3D Systems Inc.
-
GE Healthcae
-
Evonik Industries
-
Formlabs
-
Stratasys
- *Disclaimer: Major Players sorted in no particular order
Biocompatible 3D Printing Materials Market News
- June 2023: Liqcreate, a Netherlands-based 3D printing resin manufacturer, launched the Liqcreate Bio-Med Clear. This biocompatible 3D printing resin is ideal for applications that need characteristics that are not cytotoxic or irritating.
- January 2023: AGC Inc. developed a biocompatible, non-cytotoxic urethane acrylate oligomer that can be 3D printed into ultra-realistic patient-specific organ models.
Biocompatible 3D Printing Materials Industry Segmentation
As per the scope of the report, biocompatible 3D printing refers to the process of using 3D printing technology to create objects, structures, or implants that are compatible with living tissues and can be safely used in biological or medical applications. It involves the fabrication of three-dimensional objects using materials that are non-toxic, non-allergenic, and have minimal adverse effects on biological systems.
The biocompatible 3d printing materials market is segmented by material type, application, form, and geography. The market is segmented by material type into polymer, metal, and other material types. The market is segmented by application into implants & prosthesis, prototyping & surgical guides, tissue engineering, hearing aids, and other applications. By form, the market is segmented into powder and liquid. The market is segmented by geography into North America, Europe, Asia-Pacific, and the Rest of the World. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Material Type | Polymer | ||
| Metal | |||
| Other Material Types | |||
| By Application | Implants & Prosthesis | ||
| Prototyping & Surgical Guides | |||
| Tissue Engineering | |||
| Hearing Aids | |||
| Other Applications | |||
| By Form | Powder | ||
| Liquid | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
| Polymer |
| Metal |
| Other Material Types |
| Implants & Prosthesis |
| Prototyping & Surgical Guides |
| Tissue Engineering |
| Hearing Aids |
| Other Applications |
| Powder |
| Liquid |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Rest of the World |
Biocompatible 3D Printing Materials Market Research FAQs
How big is the Biocompatible 3D Printing Materials Market?
The Biocompatible 3D Printing Materials Market size is expected to reach USD 1.51 billion in 2025 and grow at a CAGR of 20.99% to reach USD 3.92 billion by 2030.
What is the current Biocompatible 3D Printing Materials Market size?
In 2025, the Biocompatible 3D Printing Materials Market size is expected to reach USD 1.51 billion.
Who are the key players in Biocompatible 3D Printing Materials Market?
3D Systems Inc., GE Healthcae, Evonik Industries, Formlabs and Stratasys are the major companies operating in the Biocompatible 3D Printing Materials Market.
Which is the fastest growing region in Biocompatible 3D Printing Materials Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Biocompatible 3D Printing Materials Market?
In 2025, the North America accounts for the largest market share in Biocompatible 3D Printing Materials Market.
What years does this Biocompatible 3D Printing Materials Market cover, and what was the market size in 2024?
In 2024, the Biocompatible 3D Printing Materials Market size was estimated at USD 1.19 billion. The report covers the Biocompatible 3D Printing Materials Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biocompatible 3D Printing Materials Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on: May 12, 2025
Biocompatible 3D Printing Materials Industry Report
Statistics for the 2025 Biocompatible 3D Printing Materials market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Biocompatible 3D Printing Materials analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
